{"title":"抗血小板治疗:血小板糖蛋白IIb/IIIa拮抗剂的最新进展。","authors":"Mousa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.</p>","PeriodicalId":80270,"journal":{"name":"Current interventional cardiology reports","volume":"1 3","pages":"243-252"},"PeriodicalIF":0.0000,"publicationDate":"1999-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists.\",\"authors\":\"Mousa\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.</p>\",\"PeriodicalId\":80270,\"journal\":{\"name\":\"Current interventional cardiology reports\",\"volume\":\"1 3\",\"pages\":\"243-252\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current interventional cardiology reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current interventional cardiology reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists.
This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
